SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-021606
Filing Date
2023-02-01
Accepted
2023-02-01 16:26:37
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d455007ds3.htm S-3 360755
2 EX-4.5 d455007dex45.htm EX-4.5 342874
3 EX-4.6 d455007dex46.htm EX-4.6 338726
4 EX-4.7 d455007dex47.htm EX-4.7 33485
5 EX-4.8 d455007dex48.htm EX-4.8 35669
6 EX-5.1 d455007dex51.htm EX-5.1 33136
7 EX-23.1 d455007dex231.htm EX-23.1 1625
8 EX-FILING FEES d455007dexfilingfees.htm EX-FILING FEES 63502
9 GRAPHIC g455007g00a03.jpg GRAPHIC 27486
10 GRAPHIC g455007g00a41.jpg GRAPHIC 33559
  Complete submission text file 0001193125-23-021606.txt   1295132
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269508 | Film No.: 23577141
SIC: 2834 Pharmaceutical Preparations